Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300078823Phase 4Recruiting
Phase 4, randomised trial of remimazolam in respiratory failure and critical illness (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Sedation compliance rate. Started Jul 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300078823.